This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of LINZESS 290 MCG capsules. The $7,599.64 firm fixed-price delivery order has an ultimate completion date of December 3, 2024.
Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is a part of that larger IDC. The contract does not have a set-aside designation, indicating open competition.
Generated 3/9/25, 12:51 AM